Testosterone is a normal hormone in women, but testosterone therapy is not standard HRT for every menopause symptom. The strongest evidence supports carefully monitored, physiologic-dose testosterone for postmenopausal women with hypoactive sexual desire disorder, not for weight loss, fatigue, or general anti-aging. In the U.S., testosterone for women is typically off-label.
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →What does testosterone do in women?
Testosterone is an androgen, which means it is part of the hormone family linked to sexual development, libido, hair follicles, skin oil glands, muscle, bone, and brain signaling. Women make testosterone too, mainly in the ovaries and adrenal glands, and some is converted in tissues from other androgen precursors 2.
Testosterone as an androgen, not just a “male hormone”
Calling testosterone a “male hormone” is too simple. Women have lower blood levels than men, but androgen receptors are found in many tissues. That does not mean more testosterone is always better; it means the hormone has real roles and real risks when levels are pushed too high 2.
How ovaries, adrenal glands, aging, and surgical menopause affect levels
Testosterone levels tend to decline with age, while estrogen drops more sharply during the menopause transition. Surgical menopause, such as removal of both ovaries, can cause a more abrupt change in ovarian hormone production, including androgens 3.
Why symptoms alone do not prove low testosterone
Low desire, fatigue, low mood, sleep problems, and weight gain can happen for many reasons. Total testosterone, free testosterone, and sex hormone-binding globulin, or SHBG, can add context, but guidelines do not support diagnosing a woman with “testosterone deficiency” from symptoms alone 2.
When might testosterone be considered for women?
Testosterone therapy for women is most often considered when a postmenopausal woman has hypoactive sexual desire disorder, or HSDD, and the concern is causing distress. The evidence is weaker in perimenopause and for non-sexual symptoms 1.
Hypoactive sexual desire disorder: what it means
HSDD means low sexual desire that is persistent, unwanted, and personally distressing. It is not the same as naturally wanting sex less often than a partner, being tired, having pain with sex, or going through a stressful life season 3.
Postmenopause vs perimenopause: where evidence is stronger or weaker
Most supportive trial evidence is in postmenopausal women. A major systematic review found that testosterone improved several sexual function measures in postmenopausal women, but evidence was not strong enough to support broad use for cognition, mood, fatigue, or general wellbeing 1.
Surgical menopause and abrupt androgen changes
After surgical menopause, hormone changes can feel sudden. Some women have bothersome low desire after ovary removal, but a clinician still needs to look at estrogen status, vaginal symptoms, pain, mood, medications, and relationship factors before considering androgen therapy 3.
Why relationship, mood, sleep, medication, pain, and vaginal symptoms matter too
Low libido can be driven by depression, anxiety, poor sleep, antidepressants, pain with sex, vaginal dryness, hot flashes, relationship stress, alcohol use, or chronic illness. Good care starts with the whole picture, not a single hormone number 3.
What benefits are supported by evidence?
The best-supported benefit is improvement in sexual desire and related distress in postmenopausal women with HSDD. Individual results vary, and benefits must be weighed against androgenic side effects and uncertain long-term safety 1.
Sexual desire, arousal, orgasm, and distress in postmenopausal HSDD
In the 2019 Lancet Diabetes & Endocrinology systematic review and meta-analysis, testosterone therapy improved sexual desire, arousal, orgasmic function, pleasure, and sexual distress in postmenopausal women compared with placebo 1. These results apply to studied products and dosing strategies, not to unmonitored use or high-dose exposure.
What the evidence does not reliably show
The same evidence base does not support testosterone as a reliable treatment for weight loss, cognition, mood, fatigue, disease prevention, or anti-aging in women 1. A separate systematic review of randomized trials also found limits and uncertainty across non-sexual outcomes 4.
Why normal testosterone blood levels do not guarantee benefit
Sexual desire is biopsychosocial. That means hormones, blood flow, mood, pain, stress, relationship safety, sleep, and medications can all matter. A “normal” total testosterone or free testosterone result does not prove that testosterone will or will not help 2.
What are the risks and side effects of testosterone therapy in women?
Side effects can happen even when testosterone is used carefully. The most common are androgenic effects such as acne, oily skin, and increased facial or body hair growth; higher exposure can raise the risk of more serious or persistent changes 1.
Common androgenic effects
At physiologic female-range exposure, trials most often report acne and increased hair growth. These effects are usually the first sign that the dose or absorption may be too high for that person 1.
Potential signs of excessive exposure
Possible signs of excessive testosterone exposure include scalp hair loss, voice deepening, clitoral enlargement, and marked hirsutism. Some changes, especially voice deepening, may not fully reverse, which is why monitoring matters 2.
Lipids, liver concerns, cardiovascular uncertainty, and breast safety limits
Oral testosterone has been linked to less favorable lipid effects and is generally discouraged in women by expert guidance 2. Long-term cardiovascular and breast safety data remain limited, especially beyond the time frames studied in trials 1.
Why long-term safety data are limited
Many trials were not large or long enough to answer rare-event safety questions. That is why guidelines narrow use to selected patients, physiologic ranges, and follow-up rather than broad wellness prescribing 2.
Why won’t some doctors prescribe testosterone for women?
Some clinicians do not prescribe testosterone for women because there is no FDA-approved testosterone product specifically indicated for women in the U.S., and the medication is a controlled substance. That does not mean it is never used; it means prescribing requires careful off-label judgment 2.
Off-label prescribing and the need for careful monitoring
Off-label prescribing is legal and common in medicine when a clinician judges it appropriate. For women, expert guidance recommends baseline assessment and follow-up labs to avoid testosterone levels above the physiologic female range 2.
Concerns about pellets, supraphysiologic dosing, and irreversible side effects
Many clinicians are cautious with pellets because they can be hard to adjust once placed and may lead to supraphysiologic levels. Guidelines favor approaches that can be adjusted or stopped if side effects occur 2.
How guidelines narrow use to specific patients
The Global Consensus Position Statement says the only evidence-based indication for testosterone therapy for women is HSDD in postmenopausal women, after a full clinical assessment 2. That narrow recommendation is one reason some doctors say no when the request is for fatigue, weight loss, or anti-aging.
How is testosterone usually given to women when prescribed?
When prescribed for women, testosterone is often given as a low-dose topical gel or cream so exposure can be adjusted. The goal in studies and guidelines is not “high testosterone”; it is avoiding levels above the typical premenopausal female range 2.
Topical gels or creams
Topical therapy is commonly discussed because it can be reduced or stopped more easily than a pellet. Clinicians also review skin transfer risk, application technique, symptoms, and blood levels during follow-up 2.
Compounded testosterone
Compounded testosterone may be used by some clinicians when no suitable commercial option exists, but compounded drugs are not FDA-approved and do not have FDA-evaluated safety, efficacy, or manufacturing data. ACOG has warned that compounded bioidentical hormone therapy should not be routinely prescribed when FDA-approved formulations are available for the clinical need 10.
Pellets and injections
Pellets and injections can expose patients to higher or less adjustable levels, depending on the product and protocol. Expert guidance urges clinicians to avoid supraphysiologic exposure because androgenic effects may be harder to control 2.
Monitoring goals
Monitoring usually focuses on symptoms, side effects, total testosterone, sometimes free testosterone or SHBG, and whether the patient is benefiting enough to continue. A lack of benefit after a fair trial is a reason to stop rather than keep escalating exposure 2.
How does testosterone compare with other treatments for midlife symptoms?
Testosterone is not the main treatment for most menopause symptoms. Estrogen therapy, with progesterone when the uterus is present, has stronger evidence for hot flashes, night sweats, some sleep disruption related to vasomotor symptoms, genitourinary symptoms, and bone protection 5.
Estrogen and progesterone
Menopausal hormone therapy usually means estrogen therapy plus progesterone when endometrial protection is needed. You can read more in our guides to hormone replacement therapy for women, HRT for menopause, and HRT side effects.
Nonhormonal options
For hot flashes, mood symptoms, sleep, and pain, nonhormonal options may include behavioral care, medication review, sleep treatment, pelvic floor care, antidepressants or other prescription options, depending on the symptom and medical history 5.
HSDD options
For HSDD, options may include testosterone in selected postmenopausal women, flibanserin, bremelanotide, counseling, sex therapy, vaginal estrogen when genitourinary symptoms are present, and medication review. Flibanserin and bremelanotide have FDA-approved labeling for certain premenopausal women with acquired, generalized HSDD 7 8.
| Symptom or goal | Options with stronger support | Where testosterone fits |
|---|---|---|
| Hot flashes or night sweats | Menopausal hormone therapy when appropriate; nonhormonal therapies when hormones are not a fit | Not a standard treatment for vasomotor symptoms |
| Vaginal dryness or pain with sex | Vaginal estrogen or other genitourinary syndrome of menopause treatments; pelvic floor care when needed | May not fix pain or dryness if estrogen deficiency is the driver |
| Low desire with distress after menopause | Full HSDD evaluation; address sleep, mood, pain, medications, and relationship factors | Most evidence-supported setting for physiologic testosterone |
| Low desire before menopause | Medication review, counseling, flibanserin or bremelanotide when appropriate, and care for pain or mood symptoms | Evidence is weaker; not a universal first step |
| Weight gain, fatigue, or brain fog | Evaluate sleep, thyroid, mood, nutrition, activity, medications, menopause symptoms, and metabolic health | Not proven as a women’s treatment for these goals |
3-min quiz
Want clinician-reviewed menopause or sexual wellness care?
Chia does not currently offer testosterone therapy for women. For eligible patients, we do offer HRT for Women with estradiol and progesterone, and Spark with PT-141 nasal spray. A licensed U.S. provider reviews your health history and prescribes only when clinically appropriate; a prescription is not guaranteed. Compounded medications through Chia are made by state-licensed 503A pharmacies and are not FDA-approved.
Women’s hormone care at Chia: what we offer and what we do not
Chia does not currently prescribe testosterone for women. We can still help some patients evaluate menopause symptoms or sexual wellness goals through the treatments in our current catalog, when a licensed provider decides they are clinically appropriate.
Chia offers HRT for Women with estradiol and progesterone
Chia’s HRT for Women protocol includes estradiol oral plus progesterone IR, with plans currently starting at $119/month. Chia also offers estradiol as cream, injection, and transdermal patch, and progesterone as cream or injection, when prescribed after clinical review.
Chia offers PT-141 nasal spray through Spark
For some sexual wellness goals, Chia offers Spark, which uses PT-141 nasal spray, with plans currently starting at $159/month. PT-141, also called bremelanotide in its FDA-approved branded form, works through melanocortin receptor pathways rather than replacing testosterone 8.
| Chia option | What it may fit | Forms in Chia catalog | Starting price |
|---|---|---|---|
| HRT for Women | Menopause hormone care when estradiol and progesterone are clinically appropriate | Estradiol oral + progesterone IR | From $119/mo |
| Estradiol | Estrogen therapy needs after provider review | Cream, injection, transdermal patch | Injection from $109/mo |
| Progesterone | Progesterone support when clinically appropriate | Cream, injection | Injection from $109/mo |
| Spark | Sexual wellness care for eligible patients | PT-141 nasal spray | From $159/mo |
| Testosterone for women | Education only at Chia right now | Not offered | Not available |
How Chia’s online evaluation works
Care at Chia starts with a short online health questionnaire. A licensed U.S. provider reviews your symptoms, health history, medications, and risk factors, then prescribes only when clinically appropriate. Patients can message the care team through the portal between visits, and prescribed compounded medications are shipped to the door from state-licensed 503A pharmacies.
Will a woman lose weight if she takes testosterone?
Testosterone should not be presented as a women’s weight-loss treatment. Studies in women do not show enough evidence to recommend it for scale weight, fatigue, or general body composition goals 1.
Menopause-related weight gain can involve sleep loss, lower activity, muscle loss with aging, medications, thyroid disease, insulin resistance, stress, alcohol, and diet patterns. If weight change is new, rapid, or paired with symptoms like palpitations, swelling, severe fatigue, or irregular bleeding, a clinician should evaluate other causes.
For weight care, testosterone is a different conversation from GLP-1 medications. Chia offers GLP-1-based weight options such as semaglutide and tirzepatide for eligible patients, but those are evaluated separately from women’s testosterone questions.
What should you ask a clinician before considering testosterone?
Before considering testosterone, ask whether HSDD is the right diagnosis and what else could be driving symptoms. A careful visit is often more useful than starting with a hormone request 3.
- Is this truly HSDD, or could pain, vaginal dryness, stress, relationship strain, depression, anxiety, sleep problems, or medication side effects be the main cause?
- Should estradiol, progesterone, vaginal estrogen, pelvic floor care, counseling, flibanserin, or bremelanotide be considered first or alongside care?
- If testosterone is used, what formulation is being prescribed, and how will you avoid levels above the physiologic female range?
- Which labs will be checked, such as total testosterone, free testosterone, SHBG, lipids, or liver-related labs?
- What side effects should prompt follow-up, such as acne, facial hair growth, scalp hair loss, voice change, or clitoral enlargement?
- What is the stopping plan if there is no meaningful benefit?
When should you get medical help now?
Get medical help promptly if you have unexplained vaginal bleeding after menopause, a new breast lump, chest pain, shortness of breath, severe pelvic pain, sudden severe headache, or neurologic symptoms. These symptoms need medical evaluation and should not be managed by changing hormones on your own.
If you are using testosterone and notice voice deepening, rapid scalp hair loss, marked facial hair growth, clitoral enlargement, severe acne, mood changes, or signs of pregnancy, contact the prescribing clinician promptly. These can be signs that the treatment is not a safe fit or that exposure is too high 2.
3-min quiz
Start with the right hormone question
If your main concerns are menopause symptoms or sexual wellness, Chia can help you review options we actually offer, including HRT for Women and Spark. Chia does not currently offer testosterone therapy for women. A prescription requires a licensed-provider evaluation and is never guaranteed.
There is no single symptom that proves a woman needs testosterone. The best-supported reason to consider it is postmenopausal hypoactive sexual desire disorder, which means low desire that is persistent, unwanted, and distressing after other causes are reviewed.
No. Standard menopausal hormone therapy usually refers to estrogen therapy, with progesterone when the uterus is present. Testosterone may be considered separately for selected women with HSDD, but it is not standard treatment for every menopause symptom.
It can be used in selected women under medical supervision, but it has risks. Side effects can include acne, oily skin, increased facial or body hair, scalp hair loss, voice deepening, and clitoral enlargement. Long-term cardiovascular and breast safety data are limited.
Current evidence does not support testosterone as a reliable treatment for fatigue, brain fog, mood, cognition, general wellness, longevity, or disease prevention in women. A clinician should look for other causes first.
Some studies included women using estrogen therapy, and some clinicians prescribe testosterone alongside menopausal hormone therapy in selected cases. This should be individualized because the reason for treatment, risk factors, formulation, and monitoring plan all matter.
No testosterone product currently has an FDA-approved indication specifically for women in the U.S. When clinicians prescribe testosterone to women, it is generally off-label and should involve careful consent, monitoring, and follow-up.
Many clinicians are cautious with pellets because they are harder to adjust after placement and can lead to higher-than-intended exposure. Guidelines generally favor approaches that can be adjusted or stopped if side effects occur.
No. Chia does not currently offer testosterone therapy for women. Chia does offer clinician-reviewed HRT for Women with estradiol and progesterone, and Spark with PT-141 nasal spray, for eligible patients when clinically appropriate.
References
- 1.Islam RM, Bell RJ, Green S, et al. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. The Lancet Diabetes & Endocrinology. 2019.
- 2.Davis SR, Baber R, Panay N, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. The Journal of Clinical Endocrinology & Metabolism. 2019.
- 3.Parish SJ, Simon JA, Davis SR, et al. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. The Journal of Women’s Health. 2021.
- 4.Achilli C, Pundir J, Ramanathan P, et al. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis. Fertility and Sterility. 2017.
- 5.The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022.
- 6.U.S. Food and Drug Administration. HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy. 2026.
- 7.U.S. Food and Drug Administration. ADDYI (flibanserin) prescribing information. 2015.
- 8.U.S. Food and Drug Administration. VYLEESI (bremelanotide) prescribing information. 2019.
- 9.U.S. Drug Enforcement Administration. Controlled Substances Act: Schedule III anabolic steroids, including testosterone. 2026.
- 10.American College of Obstetricians and Gynecologists. Clinical Consensus No. 6: Compounded Bioidentical Menopausal Hormone Therapy. Obstetrics & Gynecology. 2023.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
